Skip to main content
Julie Holden, MD, Preventive Medicine, Gaithersburg, MD

JulieRachelleHoldenMDMPH

Preventive Medicine Gaithersburg, MD

Public Health & General Preventive Medicine

Global Safety Physician at AstraZeneca

Dr. Holden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Holden's full profile

Already have an account?

Education & Training

  • Tulane University School of Public Health and Tropical Medicine
    Tulane University School of Public Health and Tropical MedicineResidency, Public Health and General Preventive Medicine, 2011 - 2012
  • Duke University Hospital
    Duke University HospitalResidency, Radiology-Diagnostic, 2009 - 2010
  • Brookwood Baptist Health
    Brookwood Baptist HealthInternship, Transitional Year, 2008 - 2009
  • Physicians Medical Center Carraway
    Physicians Medical Center CarrawayInternship, Transitional Year, 2008 - 2008
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 2008

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2010 - 2024
  • NC State Medical License
    NC State Medical License 2010 - 2013
  • American Board of Preventive Medicine Public Health & General Preventive Medicine

Publications & Presentations

PubMed

Journal Articles

  • Rationale and design of ENDEAVOR: a sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capac...  
    Lund LH, Lam CSP, Pizzato PE, Gabrielsen A, Michaëlsson E, Nelander K, Ericsson H, Holden J, Folkvaljon F, Mattsson A, Collén A, Aurell M, Whatling C, Baldus S, Drelic..., Eur J Heart Fail., 7/20/2023
  • Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial  
    Iain B Squire, Anders Gabrielsen , Peter J Greasley , Linda Wernevik , Judith Hartleib-Geschwindner , Julie Holden , Susanne Johansson , Anna Rudvik , José Sánchez , K..., Clinical and Translational Science, 8/20/2022